Efficacy and safety of Shen-Yuan-Dan capsules for peri-procedural myocardial injury following percutaneous coronary intervention: study protocol for a randomized, double-blind, placebo-controlled trial

Study Protocol ◽

Myocardial Injury ◽

Intervention Study ◽

Controlled Trial ◽

Coronary Intervention ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics

American Heart Journal ◽

10.1016/j.ahj.2018.12.015 ◽

2019 ◽

Vol 210 ◽

pp. 98-107 ◽

Cited By ~ 2

Author(s):

Roberto Ferrari ◽

Ian Ford ◽

Kim Fox ◽

Mario Marzilli ◽

Michal Tendera ◽

...

Keyword(s):

Angina Pectoris ◽

Controlled Trial ◽

Coronary Intervention ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Percutaneous Coronary ◽

Baseline Characteristics

Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(20)31790-6 ◽

2020 ◽

Vol 396 (10254) ◽

pp. 830-838 ◽

Cited By ~ 6

Author(s):

Roberto Ferrari ◽

Ian Ford ◽

Kim Fox ◽

Jean Pascal Challeton ◽

Anne Correges ◽

...

Keyword(s):

Controlled Trial ◽

Coronary Intervention ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule (芎芍胶囊) in preventing restenosis after percutaneous coronary intervention: A subgroup analysis of senile patients

Chinese Journal of Integrative Medicine ◽

10.1007/s11655-011-0843-7 ◽

2011 ◽

Vol 17 (9) ◽

pp. 669-674 ◽

Cited By ~ 27

Author(s):

Qing-hua Shang ◽

Hao Xu ◽

Xiao-yan Lu ◽

Chuan Wen ◽

Da-zhuo Shi ◽

...

Keyword(s):

Subgroup Analysis ◽

Controlled Trial ◽

Coronary Intervention ◽

Double Blind ◽

Double Blind Placebo ◽

Xiongshao Capsule ◽

Pentoxifylline for treatment of major depression after percutaneous coronary intervention or coronary artery bypass grafting: A randomized, double-blind, placebo-controlled trial

Journal of Psychosomatic Research ◽

10.1016/j.jpsychores.2021.110635 ◽

2021 ◽

pp. 110635

Author(s):

Seyyede-Ozra Yasrebi ◽

Sara Momtazmeaneh ◽

Hossein Sanjari Moghaddam ◽

Nazila Shahmansouri ◽

Maryam Mehrpooya ◽

...

Keyword(s):

Coronary Artery ◽

Coronary Artery Bypass Grafting ◽

Controlled Trial ◽

Artery Bypass ◽

Coronary Intervention ◽

Bypass Grafting ◽

Double Blind ◽

Double Blind Placebo ◽

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(15)00459-6 ◽

2016 ◽

Vol 387 (10014) ◽

pp. 136-145 ◽

Cited By ~ 59

Author(s):

Giora Weisz ◽

Philippe Généreux ◽

Andres Iñiguez ◽

Aleksander Zurakowski ◽

Michael Shechter ◽

...

Keyword(s):

Controlled Trial ◽

Coronary Intervention ◽

Double Blind ◽

Double Blind Placebo ◽

Effects on Suxiao Jiuxin Pills in the Treatment of Patients with Acute Coronary Syndrome Undergoing Early Percutaneous Coronary Intervention: A Multicenter Randomized Double-Blind Placebo-Controlled Trial

The Journal of Alternative and Complementary Medicine ◽

10.1089/acm.2020.0014 ◽

2020 ◽

Vol 26 (11) ◽

pp. 1055-1063

Author(s):

Zhijie Shen ◽

Tiejun Chen ◽

Bing Deng ◽

Ming Fan ◽

Junyi Hua ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Controlled Trial ◽

Coronary Intervention ◽

Double Blind ◽

Double Blind Placebo ◽

Coronary Syndrome ◽

Effect of Xinyue capsules on patients with coronary heart disease after percutaneous coronary intervention: study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-016-1531-x ◽

2016 ◽

Vol 17 (1) ◽

Cited By ~ 3

Author(s):

Ming Guo ◽

Ming-jie Zi ◽

Rui-xi Xi ◽

Qiao-ning Yang ◽

Rui-na Bai ◽

...

Keyword(s):

Coronary Heart Disease ◽

Randomized Controlled Trial ◽

Heart Disease ◽

Study Protocol ◽

Intervention Study ◽

Controlled Trial ◽

Coronary Intervention ◽

Randomized Controlled ◽

Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction

American Heart Journal ◽

10.1016/j.ahj.2012.12.008 ◽

2013 ◽

Vol 165 (4) ◽

pp. 509-514.e7 ◽

Cited By ~ 59

Author(s):

Anjan K. Chakrabarti ◽

Kristin Feeney ◽

Cassandra Abueg ◽

David A. Brown ◽

Ewa Czyz ◽

...

Keyword(s):

Myocardial Infarction ◽

Controlled Trial ◽

Coronary Intervention ◽

Double Blind ◽

Double Blind Placebo ◽

St Segment Elevation ◽

Segment Elevation Myocardial Infarction ◽

St Segment ◽

Comparison between Optical COherence tomography guidance and Angiography guidance in percutaneous coronary intervention (COCOA): Study protocol for a randomized controlled trial

Journal of Cardiology ◽

10.1016/j.jjcc.2018.01.005 ◽

2018 ◽

Vol 72 (2) ◽

pp. 170-175 ◽

Cited By ~ 5

Author(s):

Takashi Kubo ◽

Toshiro Shinke ◽

Takayuki Okamura ◽

Kiyoshi Hibi ◽

Gaku Nakazawa ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Optical Coherence Tomography ◽

Study Protocol ◽

Controlled Trial ◽

Coronary Intervention ◽

Optical Coherence ◽

Randomized Controlled ◽

Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial

Trials ◽

10.1186/s13063-017-2373-x ◽

2018 ◽

Vol 19 (1) ◽

Cited By ~ 1

Author(s):

Jingen Li ◽

Jianqing Ju ◽

Zhuo Chen ◽

Jing Liu ◽

Fang Lu ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Intervention Study ◽

Dual Antiplatelet Therapy ◽

Controlled Trial ◽

Coronary Intervention ◽

Randomized Controlled ◽

Percutaneous Coronary ◽

Cluster Randomized ◽

Guanxinning Tablet